Efficacy and safety of lower-carbohydrate dietary patterns for metabolic associated fatty liver disease: evidence from randomized controlled trials with grade analysis
LCDP can improve obesity and insulin resistance (IR) in MAFLD patients, and has a layered mechanism for regulating blood pressure. Its short-term effects on liver enzymes, visceral organs, and liver fat are limited, high saturated fat may weaken its effect on improving serum cholesterol.
Authors
- S N Chen
- Deyu Cong (ORCID: https://orcid.org/0009-0000-4453-1653)
- YunHang Chu
- Qi Meng
- Ziqiang Chen
- Yan Leng
- Lingyu Xu
- Rui Zhang
- Ming Yang
- Peng Dai
Institutions
- Changchun University of Chinese Medicine (CN)
- The Affiliated Hospital to Changchun University of Chinese Medicine (CN)
- Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Nutrition & Metabolism
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1186/s12986-025-01065-1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- People's Government of Jilin Province
- Department of Science and Technology of Jilin Province